SEARCH

SEARCH BY CITATION

References

  • Aymerich I, Foufelle F, Ferre P, Casado FJ & Pastor-Anglada M (2006). Extracellular adenosine activates AMP-dependent protein kinase (AMPK). J Cell Sci 119, 16121621.
  • Aymerich I, Pastor-Anglada M & Casado FJ (2004). Long term endocrine regulation of nucleoside transporters in rat intestinal epithelial cells. J Gen Physiol 124, 505512.
  • Baldwin SA, Beal PR, Yao SY, King AE, Cass CE & Young JD (2004). The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 447, 735743.
  • Baldwin SA, Mackey JR, Cass CE & Young JD (1999). Nucleoside transporters: molecular biology and implications for therapeutic development. Mol Med Today 5, 216224.
  • Bose R & Yamada EW (1977). Uridine phosphorylase activity of isolated plasma membranes of rat liver. Can J Biochem 55, 528533.
  • Bronk JR & Hastewell JG (1988). The transport and metabolism of naturally occurring pyrimidine nucleosides by isolated rat jejunum. J Physiol 395, 349361.
  • Cano-Soldado P, Larrayoz IM, Molina-Arcas M, Casado FJ, Martinez-Picado J, Lostao MP & Pastor-Anglada M (2004). Interaction of nucleoside inhibitors of HIV-1 reverse transcriptase with the concentrative nucleoside transporter-1 (SLC28A1). Antivir Ther 9, 9931002.
  • Cheng Y & Prusoff WH (1973). Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22, 30993108.
  • Del Santo B, Valdés R, Mata J, Felipe A, Casado FJ & Pastor-Anglada M (1998). Differential expression and regulation of nucleoside transport systems in rat liver parenchymal and hepatoma cells. Hepatology 28, 15041511.
  • Duflot S, Riera B, Fernandez-Veledo S, Casado V, Norman RI, Casado FJ, Lluis C, Franco R & Pastor-Anglada M (2004). ATP-sensitive K+ channels regulate the concentrative adenosine transporter CNT2 following activation by A1 adenosine receptors. Mol Cell Biol 24, 27102719.
  • Felipe A, Valdés R, Santo B, Lloberas J, Casado J & Pastor-Anglada M (1998). Na+-dependent nucleoside transport in liver: two different isoforms from the same gene family are expressed in liver cells. Biochem J 330, 9971001.
  • Griffith DA & Jarvis SM (1996). Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1286, 153181.
  • Gutierrez MM & Giacomini KM (1993). Substrate selectivity, potential sensitivity and stoichiometry of Na+-nucleoside transport in brush border membrane vesicles from human kidney. Biochim Biophys Acta 1149, 202208.
  • Hammond JR, Stolk M, Archer RG & McConnell K (2004). Pharmacological analysis and molecular cloning of the canine equilibrative nucleoside transporter 1. Eur J Pharmacol 491, 919.
  • Harris MJ, Kagawa T, Dawson PA & Arias IM (2004). Taurocholate transport by hepatic and intestinal bile acid transporters is independent of FIC1 overexpression in Madin-Darby canine kidney cells. J Gastroenterol Hepatol 19, 819825.
  • He Y, Sanderson IR & Walter WA (1994). Uptake, transport and metabolism of exogenous nucleosides in intestinal epithelial cell cultures. J Nutr 124, 19421949.
  • Lai Y, Bakken AH & Unadkat JD (2002). Simultaneous expression of hCNT1-CFP and hENT1-YFP in Madin-Darby canine kidney cells. Localization and vectorial transport studies. J Biol Chem 277, 3771137717.
  • Lostao MP, Mata JF, Larrayoz IM, Inzillo SM, Casado FJ & Pastor-Anglada M (2000). Electrogenic uptake of nucleosides and nucleoside-derived drugs by the human nucleoside transporter 1 (hCNT1) expressed in Xenopus laevis oocytes. FEBS Lett 481, 137140.
  • Mangravite LM, Badagnani I & Giacomini KM (2003). Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney. Eur J Pharmacol 479, 269281.
  • Mata JF, Garcia-Manteiga JM, Lostao MP, Fernandez-Veledo S, Guillen-Gomez E, Larrayoz IM, Lloberas J, Casado FJ & Pastor-Anglada M (2001). Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5′-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug. Mol Pharmacol 59, 15421548.
  • Nagai K, Nagasawa K & Fujimoto S (2005). Uptake of the anthracycline pirarubicin into mouse M5076 ovarian sarcoma cells via a sodium-dependent nucleoside transport system. Cancer Chemother Pharmacol 55, 222230.
  • Ngo LY, Patil SD & Unadkat JD (2001). Ontogenic and longitudinal activity of Na+-nucleoside transporters in the human intestine. Am J Physiol Gastrointest Liver Physiol 280, G475G481.
  • Pastor-Anglada M, Cano-Soldado P, Molina-Arcas M, Lostao MP, Larrayoz I, Martinez-Picado J & Casado FJ (2005). Cell entry and export of nucleoside analogues. Virus Res 107, 151164.
  • Pastor-Anglada M, Felipe A & Casado FJ (1998). Transport and mode of action of nucleoside derivatives used in chemical and antiviral therapies. Trends Pharmacol Sci 19, 424430.
  • Patil SD & Unadkat JD (1997). Sodium-dependent nucleoside transport in the human intestinal brush-border membrane. Am J Physiol Gastrointest Liver Physiol 272, G1314G1320.
  • Quaroni A, Tian JQ, Goke M & Podolsky DK (1999). Glucocorticoids have pleiotropic effects on small intestinal crypt cells. Am J Physiol Gastrointest Liver Physiol 277, G1027G1040.
  • Ritzel MW, Ng AM, Yao SY, Graham K, Loewen SK, Smith KM, Ritzel RG, Mowles DA, Carpenter P, Chen XZ, Karpinski E, Hyde RJ, Baldwin SA, Cass CE & Young JD (2001). Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol Chem 276, 29142927.
  • Rodriguez-Mulero S, Errasti-Murugarren E, Ballarin J, Felipe A, Doucet A, Casado FJ & Pastor-Anglada M (2005). Expression of concentrative nucleoside transporters SLC28 (CNT1, CNT2, and CNT3) along the rat nephron: effect of diabetes. Kidney Int 68, 665672.
  • Saito H, Nishimura M, Shinano H, Makita H, Tsujino I, Shibuya E, Sato F, Miyamoto K & Kawakami Y (1999). Plasma concentrations of adenosine during normoxia and moderate hypoxia in humans. Am J Respir Crit Care Med 159, 10141018.
  • Sarkar M, Han T, Damaraju V, Carpenter P, Cass CE & Agarwal RP (2005). Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells. Biochem Pharmacol 70, 426432.
  • Smith KM, Ng AM, Yao SY, Labedz KA, Knaus EE, Wiebe LI, Cass CE, Baldwin SA, Chen XZ, Karpinski E & Young JD (2004). Electrophysiological characterization of a recombinant human Na+-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes. J Physiol 558, 807823.
  • Sundaram M, Yao SY, Ng AM, Griffiths M, Cass CE, Baldwin SA & Young JD (1998). Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs. J Biol Chem 273, 2151921525.
  • Toan SV, To KW, Leung GP, De Souza MO, Ward JL & Tse CM (2003). Genomic organization and functional characterization of the human concetrative nucleoside transporter-3 isoform expressed in mammalian cells. Pflugers Arch 447, 195204.
  • Valdés R, Ortega MA, Casado FJ, Felipe A, Gil A, Sanchez-Pozo A & Pastor-Anglada M (2000). Nutritional regulation of nucleoside transporter expression in rat small intestine. Gastroenterology 119, 16231630.
  • Van Aubel RA, Masereeuw R & Russel FG (2000). Molecular pharmacology of renal organic anion transporters. Am J Physiol Renal Physiol 279, F216F232.
  • Ward JL, Sherali A, Mo ZP & Tse CM (2000). Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J Biol Chem 275, 83758381.
  • Wu SK, Ann DK, Kim KJ & Lee VH (2005). Fine tuning of rabbit equilibrative nucleoside transporter activity by an alternatively spliced variant. J Drug Target 13, 521533.
  • Zhang J, Sun X, Smith KM, Visser F, Carpenter P, Barron G, Peng Y, Robins MJ, Baldwin SA, Young JD & Cass CE (2006). Studies of nucleoside transporters using novel autofluorescent nucleoside probes. Biochemistry 45, 10871098.
  • Zou AP, Nithipatikom K, Li PL & Cowley AW (1999). Role of medullary adenosine in the control of blood flow and sodium excretion. Am J Physiol Reg Int Comp Physiol 45, R790R798.